Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Infectious Diseases|August 15, 2022
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static ModelAlexia Kieffer, Matthieu Beuvelet, Aditya Sardesai, et al.
Global & Regional Health Technology Assessment|February 3, 2025
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in ItalyAndrea Marcellusi, Chiara Bini, Barbara Muzii, et al.
Pulmonary Therapy|February 26, 2026
Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling StudyBenjamin Yarnoff, Maureen P Neary, Veronica Gabriel, et al.
Expert Review of Vaccines|November 18, 2025
Comparison of the public health impact of RSV disease prevention options for infants: a static decision model of the US birth cohortAlexia Kieffer, Mehdi Ghemmouri, Samira Soudani, et al.
Pageof 1